- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Bochum, Ruhr-Universität Bochum, Dissertation, 2019
- Schlagwort
-
Melanoma
Melanom
Antikörper
Stammzelle
Krebs (Medizin)
Therapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Bochum
- (wer)
-
Ruhr-Universität Bochum
- (wann)
-
2019
- Urheber
- Beteiligte Personen und Organisationen
-
Stockfleth, Eggert
El Gammal, A. K. Stephan
Medizinische Fakultät
- URN
-
urn:nbn:de:hbz:294-64754
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stoyanova, Ani K.
- Stockfleth, Eggert
- El Gammal, A. K. Stephan
- Medizinische Fakultät
- Ruhr-Universität Bochum
Entstanden
- 2019
Ähnliche Objekte (12)
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody therapy
Clinical protein science in translational medicine targeting malignant melanoma
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma
Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody
Pathology of malignant melanoma
Immunotherapy of malignant melanoma
Pathobiology of malignant melanoma
Epidemiology of malignant melanoma
Management of Malignant Melanoma
The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma
Monoclonal antibody applications in travel medicine
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody therapy
Clinical protein science in translational medicine targeting malignant melanoma
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma
Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody
Pathology of malignant melanoma
Immunotherapy of malignant melanoma
Pathobiology of malignant melanoma
Epidemiology of malignant melanoma
Management of Malignant Melanoma
The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma
Monoclonal antibody applications in travel medicine
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody therapy
Clinical protein science in translational medicine targeting malignant melanoma
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma
Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody
Pathology of malignant melanoma
Immunotherapy of malignant melanoma
Pathobiology of malignant melanoma
Epidemiology of malignant melanoma
Management of Malignant Melanoma
The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma